AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and Linkedin.
Alimetry develops breakthrough non‐invasive diagnostic solutions for disorders of gastrointestinal function and motility. Gastric Alimetry is the flagship product for Alimetry, and uses body surface gastric mapping combined with validated patient symptom profiling to assist in the diagnosis of neuromuscular dysfunction, disorders of brain‐gut interaction, gut hypersensitivity, gastric outlet resistance and small bowel symptoms.
At Ardelyx, we are dedicated to improving the lives of patients by discovering, developing and commercializing innovative, first‐in‐class medicines that meet significant unmet medical needs.
BK Medical, now with GE HealthCare, is committed to providing innovative active imaging solutions that help physicians visualize anatomy, plan treatment, and evaluate outcomes for procedures. Driven by our mission to change the standard of care with real‐time visual guidance we provide high‐resolution images and data‐driven insights when it matters.
Blueprint Medicines is a global precision therapy company that aims to invent life‐changing medicines for people with cancer and blood disorders. Applying an approach that is both precise and agile, we create therapies that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. We are delivering our approved medicines to patients in the United States and Europe, and we are globally advancing multiple programs for systemic mastocytosis, lung cancer and other genomically defined cancers, and cancer immunotherapy.
CAIRN Diagnostics Test with Confidence.
CAIRN Diagnostics 13C‐Spirulina Gastric Emptying Breath Test (GEBT) is intended for use in the measurement of the rate of gastric emptying of solids and as an aid in the diagnosis of delayed gastric emptying (gastroparesis) in adults. GEBT is an FDA‐approved, non‐radioactive, non‐ invasive, orally administered, standardized, office‐based test and also now FDA‐Approved virtual “at‐home use” via telehealth. GEBT was validated against the 4‐hour gold standard reference method of gastric scintigraphy (Mayo, Rochester). GEBT can be administered in the physician’s office and does not require specialized imaging equipment, licensed facilities or personnel, or radioactive material. Breath samples are sent by overnight courier to Cairn’s CLIA clinical laboratory and analyzed on FDA approved, high precision, gas isotope ratio mass spectrometers. A comprehensive gastric emptying report is then sent to the ordering physician through a secure online portal. GEBT has received a dedicated CPT code and Medicare reimbursement. GEBT is now guideline recommended for gastroparesis diagnosis (ACG, AGA, EUC).
Diversatek Healthcare
Science, technology and an untiring commitment to GI Care. It’s in everything we do. At Diversatek Healthcare, we’re dedicated to expanding our comprehensive range of diagnostic and therapeutic GI applications – all to help you provide exceptional patient care. As of January 1, 2022 Diversatek Healthcare received new APC assignment for MiVu™ from CMS for Hospital Outpatient and Ambulatory Surgery Centers. MiVu™ is the first GERD diagnostic tool to detect esophageal mucosal changes instantly during routine endoscopy, potentially reducing diagnostic and treatment latency.
Doctors Biome
The Doctor’s Biome team of doctors have created a signature probiotic blend of 15 strains of living probiotics that have been chosen from clinical studies, especially those beneficial to compete against C. difficile and other intestinal conditions.
Unlike most other probiotics on the market, our probiotics are pre‐hydrated in a 100% organic vegetable and fruit juice blend, making them physiologically active and growing from the date of manufacture. As our product ages, the number of probiotics inside it are increasing! (providing you don’t exceed the best by date). We will be unveiling our Medical Food product for the first time!
Enterra Medical
Enterra Medical is a medical device company dedicated to a singular focus: helping more people with chronic gastroparesis live better lives by advancing technology, expanding clinical science, and accelerating access to Enterra Therapy. Unlike diet modifications or surgery, the Enterra System is the first and only device designed which may help relieve chronic, drug‐ refractory nausea and vomiting symptoms secondary to diabetic or idiopathic gastroparesis. Enterra Therapy was approved in 2000 under a Humanitarian Device Exemption (effectiveness has not been demonstrated), approved to be safe and to have probable benefit for chronic drug‐refractory nausea and vomiting due to gastroparesis of diabetic and idiopathic origin in patients aged 18‐70. A small, implantable device that’s customizable and reversible, the Enterra System gently stimulates the stomach, designed to help reduce nausea and vomiting associated with gastroparesis. Over 15,000 people have received Enterra Therapy to help resume everyday activities.
Evoke Pharma® is a specialty pharmaceutical company primarily focused on the development of drugs that treat gastrointestinal disorders and diseases. The company offers Gimoti® (metoclopramide) nasal spray for the relief of symptoms associated with the acute and recurrent diabetic gastroparesis in adults.
Gemelli Biotech develops and distributes precision diagnostics for diseases of the gut microbiome. Our mission is to leverage leading biological discoveries related to the microbiome to provide non‐invasive precision diagnostics which enable clinicians to definitively detect scientifically validated biomarkers and optimally treat GI diseases including SIBO, IMO, excess hydrogen sulfide, and post‐infectious IBS. Our products include the trio‐smart® breath test that measures levels of hydrogen, methane, and hydrogen sulfide and the IBS‐smart® blood test that measures validated biomarkers of IBS, anti‐CdtB, and anti‐vinculin, offering a positive diagnostic strategy for patients with IBS symptoms.
IB‐Stim
The IB‐Stim is a percutaneous electrical nerve field stimulator (PENFS) system intended to be used in patients 11‐18 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS). The IB‐Stim is intended to be used for 120 hours per week up to 3 consecutive weeks, through application to branches of Cranial Nerves V, VII, IX and X, and the occipital nerves identified by transillumination, as an aid in the reduction of pain when combined with other therapies for IBS.
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. We continue to build upon our history of GI innovation and challenge what has been done before to shape the future. We keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.
Konsyl Pharmaceuticals, Inc is a global brand celebrating 85 years of supporting the health and wellness of millions of customers by delivering high quality digestive and wellness products. Sitzmarks Radiopaque Markers are a safe, non‐invasive diagnostic tool for patients who are suffering from persistent constipation.
Laborie Medical Technologies
At Laborie, we believe that great healthcare is an essential safeguard of human dignity. Our Mission every day is to operate as a world‐class specialist medical company making and advancing technologies that preserve and restore human dignity. We do that today by helping people with pelvic and gastrointestinal conditions live normal lives, and by helping mothers and babies have safe deliveries.
Mahana Therapeutics is a leading provider of personalized digital therapeutics that empower people with chronic conditions to live fuller lives. The company’s first treatment, Mahana™ IBS, is the first FDA‐cleared prescription digital therapy to deliver cognitive behavioral therapy (CBT) for adults with irritable bowel syndrome (IBS) and is suitable for patients with all types of IBS. Mahana is developing a robust pipeline of accessible, clinically‐validated prescription digital therapies for the treatment of chronic health conditions to reduce disease burden and enrich the lives of individuals impacted by life‐impacting chronic conditions. More information is available at Mahana.com
Mayo Clinic Laboratories
Mayo Clinic Laboratories strives to ensure patients around the world have access to the most advanced diagnostic testing. Working with hospitals and health care providers worldwide, we deliver the latest in diagnostic testing to provide answers and improve outcomes for their patients. With the world’s most sophisticated test catalog, our testing incorporates scientific discoveries, cutting‐edge technologies, and unparalleled expertise to solve the most rare and complicated cases.
Medspira, the market leader in portable Anorectal Manometry, offers mcompass® – designed for ease of use and low operating cost, especially for Pediatric, Gastrointestinal, and Colorectal practices.
The market leading mcompass® Manometric Biofeedback, the only such therapy device that is FDA cleared, is for Pelvic Floor retraining for such conditions as Chronic Constipation, Incontinence, Dyssynergia, and Impaired Rectal Sensation.
Providing a high patient flow rate and the greatest available reimbursements, mcompass® makes Medspira your USA‐based Pelvic Floor Solutions provider!
Medtronic
We lead global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. Expect more from us. Medtronic. Engineering the extraordinary.
Phathom Pharmaceuticals
Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new treatments for gastrointestinal (GI) disorders. We have licensed the exclusive rights in the United States, Europe, and Canada for an investigational potassium‐ competitive acid blocker (PCAB) which the company is developing for the treatment of certain GI disorders.
Salix Pharmaceuticals
For 30 years, Salix Pharmaceuticals has been committed to the prevention and treatment of gastrointestinal diseases. Salix licenses, develops, and markets innovative products to improve patients’ lives and arm healthcare providers with life‐ changing solutions. Salix is headquartered in Bridgewater, New Jersey.
Vibrant Gastro is the pioneer of the Synchronized Activation Method™, a first‐in‐class drug‐free technology that is the driving force behind the Vibrant system.
Vibrant utilizes pre‐programmed microvibrations to stimulate the colon mechanically, improving natural colonic motility.
Vibrant is FDA‐cleared, effective and safe treatment for adults with chronic idiopathic constipation (CIC) who have not experienced relief with the use of laxative therapies at the recommended dosage for at least one month.